Close Menu

stock offering

NEW YORK (GenomeWeb News) – Exact Sciences today said that it raised $73.4 million in net proceeds from a previously announced public offering of its common stock.

The story has been updated with information about the pricing of the notes released by Agilent after the close of the market.

NEW YORK (GenomeWeb News) – Exact Sciences today priced its public offering of 5.5 million shares of its common stock at $12.35 per share with anticipated net proceeds of about $63.7 million.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that the underwriters of its recently announced $2.2 billion public offering of common stock have exercised their

NEW YORK (GenomeWeb News) – Cancer Genetics has filed a preliminary prospectus to offer $15 million in a public offering of its stock.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific announced after the close of the market on Wednesday a public offering of $2.2 billion of its common stock.

NEW YORK (GenomeWeb News) – Hitachi High-Technologies will distribute Nanosphere's products in Japan as part of a deal announced by Nanosphere after the close of the market on Monday.

NEW YORK (GenomeWeb News) – WaferGen BioSystems said in a regulatory document that revenues for its first quarter more than doubled year over year.
It separately also announced a stock sale by shareholders of up to more than 112 million shares.

NEW YORK (GenomeWeb News) – Nanosphere today said that its first-quarter revenues jumped 85 percent year over year as consumables sales rose 123 percent.
The company also said that it secured $27 million in new financing.

Arrowhead Research this week announced that it intends to raise $36 million through a private offering of roughly 14.3 million shares plus 9,900 shares of convertible preferred stock.

Pages

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.